Nintenib 150 Soft Gelatin Capsule
Prescription Required
Product introduction
Nintenib 150 Soft Gelatin Capsule is used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. It works by targeting certain pathways involved in the growth and progression of these diseases and helps to stop or slow the spread of cancer cells.
Nintenib 150 Soft Gelatin Capsule is used to treat different types of cancer
Nintenib 150 Soft Gelatin Capsule is used to treat different types of cancer
Uses of Nintenib Soft Gelatin Capsule
Benefits of Nintenib Soft Gelatin Capsule
In Treatment of Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis is a lung disease caused by lung tissue becoming thick and stiff and eventually forming scar tissue within the lungs. The scarring, or fibrosis, seems to result from a cycle of damage and healing that occurs in the lungs. These changes are irreversible and the affected person may experience shortness of breath or dry cough as initial symptoms. Nintenib 150 Soft Gelatin Capsule kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. You may experience some bothersome side effects. Discuss with your doctor if you have any doubts.
In Treatment of Non-small cell lung cancer
Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Nintenib 150 Soft Gelatin Capsule helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side effects of Nintenib Soft Gelatin Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Nintenib
- Diarrhea
- Nausea
- Abdominal pain
- Vomiting
- Abnormal liver function tests
- Loss of appetite
- Headache
- Weight loss
- High blood pressure
How to use Nintenib Soft Gelatin Capsule
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nintenib 150 Soft Gelatin Capsule is to be taken with food.
How Nintenib Soft Gelatin Capsule works
Nintenib 150 Soft Gelatin Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. It also blocks pathways in the body that result in fibrosis, which is the thickening or scarring of the tissue. This helps to stop or slow the spread of cancer cells.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Nintenib 150 Soft Gelatin Capsule. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Nintenib 150 Soft Gelatin Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Nintenib 150 Soft Gelatin Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Nintenib 150 Soft Gelatin Capsule may cause side effects which could affect your ability to drive.
You may feel sick after taking this medicine and this could affect your driving.
You may feel sick after taking this medicine and this could affect your driving.
Kidney
CAUTION
Nintenib 150 Soft Gelatin Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Nintenib 150 Soft Gelatin Capsule may be needed. Please consult your doctor.
There is limited information available on the use of Nintenib 150 Soft Gelatin Capsule in these patients.
There is limited information available on the use of Nintenib 150 Soft Gelatin Capsule in these patients.
Liver
CAUTION
Nintenib 150 Soft Gelatin Capsule should be used with caution in patients with liver disease. Dose adjustment of Nintenib 150 Soft Gelatin Capsule may be needed. Please consult your doctor.
Use of Nintenib 150 Soft Gelatin Capsule is not recommended in patients with moderate to severe liver disease.
Use of Nintenib 150 Soft Gelatin Capsule is not recommended in patients with moderate to severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Nintenib 150 Soft Gelatin Capsule
₹90.0/Soft Gelatin Capsule
Cyendiv 150mg Soft Gelatin Capsule
Boehringer Ingelheim
₹2598.5/soft gelatin capsule
2787% costlier
Nintena 150mg Soft Gelatin Capsule
Sun Pharmaceutical Industries Ltd
₹45/soft gelatin capsule
50% cheaper
Nindanib 150 Soft Gelatin Capsule
Glenmark Pharmaceuticals Ltd
₹90/soft gelatin capsule
same price
Idofnib 150 Soft Gelatin Capsule
Lupin Ltd
₹90/soft gelatin capsule
same price
Nindev 150mg Soft Gelatin Capsule
Zydus Cadila
₹99.5/soft gelatin capsule
11% costlier
Fact Box
Chemical Class
Indolecarboxylic Acids
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Nintedanib. Ridgefield, Connecticut: Boehringer Ingelheim Pharmaceuticals, Inc.; 2014. [Accessed 26 Mar. 2019] (online) Available from:
- Nintedanib esilate. Bracknell, Berkshire: Boehringer Ingelheim Limited; 2015 [revised 31 Oct. 2018]. [Accessed 26 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Nintedanib. [Accessed 26 Mar. 2019] (online) Available from:
- CiplaMed. Nintedanib [Prescribing Information]. [last Revised: 19 Mar. 2021]. [Accessed 02 Aug. 2023] (online) Available from:
Marketer details
Name: BDR Pharmaceuticals Internationals Pvt
Address: 407-408, Sharda Chambers, New Marine Lines, Mumbai 400 020 (Maharashtra), New Marine Lines, Marine Lines, Mumbai, Maharashtra 400020
Country of origin: India
Lab tests offered by us
Related/Popular tests
130 people viewed this recentlyMRP
₹900
Inclusive of all taxes
10.0 soft gelatin capsules in 1 strip
SOLD OUT
Notify me